Ebit Alterar Data
AbbVie USD 6.72B 1.99B 2026-06
Amgen USD 4.61B 777M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Canopy Growth CAD -145.65M 132.99M 2026-03
Corcept Therapeutics USD 41.3M 90.9M 2026-06
Drreddys Laboratories INR 3.05B 13.32B 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Genmab DKK 260M 199M 2025-12
GlaxoSmithKline GBP 2.6B 312M 2026-06
Glaxosmithkline GBP 2.31B 14.92M 2026-03
J&J USD 7.48B 860M 2026-06
Lakefront Biotherapeutics EUR -63.7M 844.26M 2026-03
Merck USD 840M 2.72B 2026-06
Novartis USD 4.73B 549M 2026-06
Novartis USD 4.18B 118M 2026-03
Pacira USD 9.96M 5.33M 2026-06
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD -180M 5.16B 2026-06
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 75.49M 7M 2026-03
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 1.12B 811M 2026-06
Sanofi EUR 2.18B 1.56B 2026-03
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
UCB EUR 1.29B 571M 2025-12
Zoetis USD 842M 7M 2026-03